Zhang Ruoyu, Lee Sang Mee, Wigfield Chris, Vigneswaran Wickii T, Ferguson Mark K
Section of Thoracic, Cardiac, Transplant and Vascular Surgery, Department of Surgery, Hannover Medical School, Hannover, Germany.
Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
Ann Thorac Surg. 2015 May;99(5):1761-7. doi: 10.1016/j.athoracsur.2015.01.030. Epub 2015 Mar 25.
Although postoperative predicted forced expiratory volume in the first second and diffusing capacity of lung (ppoFEV1% and ppoDLCO%, respectively) have been identified as independent predictors of postoperative pulmonary complications after open lobectomy, it has been suggested that their predictive abilities may not extend to patients undergoing minimally invasive lobectomy.
We evaluated outcomes in 805 patients undergoing isolated lobectomy through open (n = 585) or minimally invasive approaches (n = 220) using a prospective database. Demographic and physiologic data were extracted and compared with complications classified as pulmonary, cardiac, other, mortality, and any.
Patients included 428 women and 377 men; mean age was 65.0 years. Minimally invasive patients were older (66.6 versus 64.3 years, p = 0.006), had better ppoFEV1% (71.5% versus 65.6%, p < 0.001) and performance status (0,1 94.1% versus 88.4%, p = 0.017), and less often underwent induction therapy (0.5% versus 4.8%, p = 0.003). Pulmonary and other complications were less common after minimally invasive lobectomy (3.6% versus 10.4%, p = 0.0034; 8.6% versus 15.8%, p = 0.008). Operative mortality occurred in 1.4% of minimally invasive patients and 3.9% of open patients (p = 0.075). Pulmonary complication incidence was related to predicted postoperative lung function for both minimally invasive and open approaches. On multivariate analysis with stratification for stage, ppoFEV1% and ppoDLCO% were predictive of pulmonary complications for both minimally invasive and open approaches.
Our results suggest that the predictive abilities of ppoFEV1% and ppoDLCO% are retained for minimally invasive lobectomy and can be used to estimate the risk of pulmonary complications.
尽管术后第1秒用力呼气容积和肺弥散功能(分别为ppoFEV1%和ppoDLCO%)已被确定为开胸肺叶切除术后肺部并发症的独立预测指标,但有人认为它们的预测能力可能不适用于接受微创肺叶切除术的患者。
我们使用前瞻性数据库评估了805例接受单纯肺叶切除术的患者的结局,其中开胸手术(n = 585)或微创手术(n = 220)。提取人口统计学和生理学数据,并与分为肺部、心脏、其他、死亡率和任何并发症进行比较。
患者包括428名女性和377名男性;平均年龄为65.0岁。微创患者年龄较大(66.6岁对64.3岁,p = 0.006),ppoFEV1%更好(71.5%对65.6%,p < 0.001)且功能状态更好(0、1级94.1%对88.4%,p = 0.017),接受诱导治疗的频率更低(0.5%对4.8%,p = 0.003)。微创肺叶切除术后肺部和其他并发症较少见(3.6%对10.4%,p = 0.0034;8.6%对15.8%,p = 0.008)。手术死亡率在1.4%的微创患者和3.9%的开胸患者中发生(p = 0.075)。肺部并发症发生率与微创和开胸手术的术后预测肺功能相关。在按分期分层的多变量分析中,ppoFEV1%和ppoDLCO%对微创和开胸手术的肺部并发症均具有预测性。
我们的结果表明,ppoFEV1%和ppoDLCO%的预测能力在微创肺叶切除术中仍然存在,可用于估计肺部并发症的风险。